Page last updated: 2024-11-03

propofol and Tuberous Sclerosis

propofol has been researched along with Tuberous Sclerosis in 1 studies

Propofol: An intravenous anesthetic agent which has the advantage of a very rapid onset after infusion or bolus injection plus a very short recovery period of a couple of minutes. (From Smith and Reynard, Textbook of Pharmacology, 1992, 1st ed, p206). Propofol has been used as ANTICONVULSANTS and ANTIEMETICS.
propofol : A phenol resulting from the formal substitution of the hydrogen at the 2 position of 1,3-diisopropylbenzene by a hydroxy group.

Tuberous Sclerosis: Autosomal dominant neurocutaneous syndrome classically characterized by MENTAL RETARDATION; EPILEPSY; and skin lesions (e.g., adenoma sebaceum and hypomelanotic macules). There is, however, considerable heterogeneity in the neurologic manifestations. It is also associated with cortical tuber and HAMARTOMAS formation throughout the body, especially the heart, kidneys, and eyes. Mutations in two loci TSC1 and TSC2 that encode hamartin and tuberin, respectively, are associated with the disease.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Li, W1
Wait, SD1
Ogg, RJ1
Scoggins, MA1
Zou, P1
Wheless, J1
Boop, FA1

Other Studies

1 other study available for propofol and Tuberous Sclerosis

ArticleYear
Functional magnetic resonance imaging of the visual cortex performed in children under sedation to assist in presurgical planning.
    Journal of neurosurgery. Pediatrics, 2013, Volume: 11, Issue:5

    Topics: Anesthetics, Intravenous; Brain Mapping; Child; Child, Preschool; Conscious Sedation; Female; Humans

2013